Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 16: 660-664, 1961;
8750-7587/61 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pilgeram, L. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pilgeram, L. O.

Relation of plasma fibrinogen concentration changes to human arteriosclerosis

L. O. Pilgeram 1

1 Arteriosclerosis Research Laboratory, St. Barnabas Hospital Research Foundation; and Department of Physiology, University of Minnesota School of Medicine, Minneapolis, Minnesota

A 35% increase (P < 0.001) in plasma fibrinogen levels was found in patients who recovered from the trauma of myocardial infarction and had not received anticoagulant therapy for 5 months preceding donation of plasma. The elevated fibrinogen levels are not a consequence of inflammatory conditions or traumatized tissue resulting from clinically overt vascular incidents. The fibrinogen level does not return to normal following a myocardial infarction. Occlusion of beta lipoproteins in the fibrin coagulum did not account for elevated levels of fibrinogen as shown by experiments where a) known quantities of alpha and beta lipoproteins were added to the test system, b) correction was made for the occlusion factor, and c) the increased yield due to this occlusion factor represented only a 3.5% increase in fibrinogen yield for as much as 300% increase in the level of beta lipoproteins. The fibrinogen level not only increases with age but also superimposes upon the arteriosclerotic an increase in addition to that occurring with increasing chronologic age. The role of fibrin in vascular hypertrophy and atheromatous development is emphasized. Possible causes for abnormal levels of fibrinogen are discussed.

Note:
(With the Technical Assistance of A. C. Schram and D. Mills)

Submitted on December 5, 1960







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online